RAPT — RAPT Therapeutics Inc

Ownership history in Column Group LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which Column Group LLC reported a position in RAPT Therapeutics Inc (RAPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
44.0% (2023 Q4)
Avg. % of fund
13.0%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 156,270 -9,805 -5.9% 6.39% $5.3M $33.87
2025 Q3 REDUCED 166,075 -1,162,538 -87.5% 5.29% $4.3M $25.79
2025 Q2 UNCHANGED 1,328,613 — 0% 16.17% $10.6M $8.00
2025 Q1 UNCHANGED 1,328,613 — 0% 3.67% $1.6M $9.76
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RAPT price (monthly, adj. close)

Other funds also holding RAPT

As of 2025 Q4 — sorted by position size

Medicxi Ventures Management (Jersey) Ltd 3Y 11.33% FCPM III SERVICES B.V. 8.14% GREAT POINT PARTNERS LLC 3Y 7Y 6.38% BOONE CAPITAL MANAGEMENT LLC 3Y 5.0% TCG Crossover Management, LLC 3Y 2.89% Octagon Capital Advisors LP 3Y 2.36% Redmile Group, LLC 3Y 7Y 2.21% Velan Capital Investment Management LP 3Y 2.12% Caligan Partners LP 3Y 1.8% Ikarian Capital, LLC 3Y 1.76%
← Back to Column Group LLC Holdings